FdaApplication

NDA 019520

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBAXTER HEALTHCARE CORP
application_typeNDA
approval_date1988-09-23

Products (10)

ProductActive ingredientStrengthDosage form
TRAVASOL 2.75% IN DEXTROSE 10% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE2.75%;10GM/100MLINJECTABLE;INJECTION
TRAVASOL 2.75% IN DEXTROSE 15% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE2.75%;15GM/100MLINJECTABLE;INJECTION
TRAVASOL 2.75% IN DEXTROSE 20% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE2.75%;20GM/100MLINJECTABLE;INJECTION
TRAVASOL 2.75% IN DEXTROSE 25% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE2.75%;25GM/100MLINJECTABLE;INJECTION
TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE2.75%;5GM/100MLINJECTABLE;INJECTION
TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE4.25%;10GM/100MLINJECTABLE;INJECTION
TRAVASOL 4.25% IN DEXTROSE 15% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE4.25%;15GM/100MLINJECTABLE;INJECTION
TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE4.25%;20GM/100MLINJECTABLE;INJECTION
TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE4.25%;25GM/100MLINJECTABLE;INJECTION
TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINERAMINO ACIDS; DEXTROSE4.25%;5GM/100MLINJECTABLE;INJECTION

10 products